Early weight loss with liraglutide 3.0 mg is a good predictor of clinically meaningful weight loss after 56 weeks

被引：0
|
作者：
Le Roux, Carel [1 ]
Bluher, Matthias [2 ]
Hermansen, Kjeld [3 ]
Greenway, Frank [4 ]
Fujioka, Ken [5 ]
Donsmark, Morten [6 ]
Jensen, Christine [6 ]
Wilding, John [7 ]
机构：
[1] Univ Coll Dublin, Dublin, Ireland
[2] Univ Leipzig, Leipzig, Germany
[3] Aarhus Univ Hosp, Aarhus, Denmark
[4] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA
[5] Scripps Clin, La Jolla, CA 92037 USA
[6] Novo Nordisk AS, Soborg, Denmark
[7] Univ Liverpool, Liverpool, Merseyside, England
来源：
BRITISH JOURNAL OF SURGERY | 2017年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
E06
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [31] Liraglutide promotes weight maintenance and additional weight loss in obese adults without diabetes after diet-induced weight loss: the SCALE™ 56-week randomised study
    Woo, V. C.
    Hollander, P. A.
    Niswender, K. D.
    Klein, S.
    Aronne, L. J.
    Jensen, C. B.
    Le Thi, T. D.
    Wadden, T.
    DIABETOLOGIA, 2011, 54 : S39 - S39
  • [32] Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced Type 2 diabetes development at three years vs early non-responders: SCALE Obesity and Prediabetes
    Le Roux, C. W.
    Lau, D. C. W.
    Fujioka, K.
    Greenway, F.
    Wilding, J. P. H.
    Jacobsen, P. B.
    Skjoth, T.
    Madsbad, S.
    DIABETIC MEDICINE, 2017, 34 : 57 - 57
  • [33] Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss
    Yassin, A. A.
    Doros, G.
    CLINICAL OBESITY, 2013, 3 (3-4) : 73 - 83
  • [34] Response to NB at Week 16 Is a Good Predictor of Significant Week 56 Weight Loss and Improvements in Weight-Related Risk Factors
    Plutzky, Jorge
    Buse, John
    Chilton, Robert
    Mignon, Laurence
    Burns, Colleen
    Harris-Collazo, Raul
    Klassen, Preston
    Dunayevich, Eduardo
    DIABETES, 2011, 60 : A700 - A700
  • [35] Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
    T A Wadden
    P Hollander
    S Klein
    K Niswender
    V Woo
    P M Hale
    L Aronne
    International Journal of Obesity, 2013, 37 : 1443 - 1451
  • [36] Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
    Wadden, T. A.
    Hollander, P.
    Klein, S.
    Niswender, K.
    Woo, V.
    Hale, P. M.
    Aronne, L.
    INTERNATIONAL JOURNAL OF OBESITY, 2013, 37 (11) : 1443 - 1451
  • [37] Early Weight Loss While on Lorcaserin, Diet and Exercise as a Predictor of Week 52 Weight-Loss Outcomes
    Smith, Steven R.
    O'Neil, Patrick M.
    Astrup, Arne
    Finer, Nicholas
    Sanchez-Kam, Matilde
    Fraher, Kyle
    Fain, Randi
    Shanahan, William R.
    OBESITY, 2014, 22 (10) : 2137 - 2146
  • [38] FACTORS ASSOCIATED WITH SUCCESSFUL WEIGHT LOSS AFTER LIRAGLUTIDE TREATMENT FOR OBESITY
    Sannaa, Wassel
    BouSaba, Joelle
    Maselli, Daniel B.
    Atieh, Jessica
    Eckert, Deborah J.
    Taylor, Ann
    Harmsen, William S.
    Acosta, Andres
    Camilleri, Michael
    GASTROENTEROLOGY, 2022, 162 (07) : S171 - S171
  • [39] Factors associated with successful weight loss after liraglutide treatment for obesity
    Sannaa, Wassel
    Dilmaghani, Saam
    BouSaba, Joelle
    Maselli, Daniel
    Atieh, Jessica
    Eckert, Deborah
    Taylor, Ann L.
    Harmsen, W. Scott
    Acosta, Andres
    Camilleri, Michael
    DIABETES OBESITY & METABOLISM, 2023, 25 (02): : 377 - 386
  • [40] A randomized, double-blind, placebo-controlled trial of weight loss using liraglutide 3.0 mg for weight recurrence after Roux-en-Y gastric bypass
    Lofton, Holly F.
    Maranga, Gabrielle
    Hold, Robert
    Fielding, George
    Youn, Heekoung
    Gujral, Akash
    Heffron, Sean
    Fielding, Christine
    SURGERY FOR OBESITY AND RELATED DISEASES, 2025, 21 (02) : 135 - 145
12345